• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法布里病:对一个携带新型突变(30delG)的家系进行携带者检测时酶学分析、连锁分析和突变分析的比较

Fabry disease: comparison of enzymatic, linkage, and mutation analysis for carrier detection in a family with a novel mutation (30delG).

作者信息

Ashton-Prolla P, Ashley G A, Giugliani R, Pires R F, Desnick R J, Eng C M

机构信息

Department of Human Genetics, Mount Sinai School of Medicine, New York, New York 10029, USA.

出版信息

Am J Med Genet. 1999 Jun 11;84(5):420-4. doi: 10.1002/(sici)1096-8628(19990611)84:5<420::aid-ajmg6>3.0.co;2-z.

DOI:10.1002/(sici)1096-8628(19990611)84:5<420::aid-ajmg6>3.0.co;2-z
PMID:10360396
Abstract

Fabry disease (FD) is an X-linked recessive disorder caused by the deficient activity of the lysosomal enzyme alpha-galactosidase A (alpha-Gal A). Affected males are reliably diagnosed by demonstration of deficient alpha-Gal A activity in plasma or leukocytes. However, identification of female carriers is problematic due to Lyonization, requiring mutation identification and/or linkage studies for accurate carrier detection. Here, we describe a large Brazilian kindred with Fabry disease that permitted comparison of biochemical and molecular diagnostic techniques. Initially, the plasma alpha-Gal A activities were determined in at-risk affected males and potential female carriers; affected males were readily diagnosed, while the females had variable results. To detect carrier females, haplotype analysis using 10 polymorphic markers adjacent to the gene was performed. Subsequently, solid-phase direct sequencing of the alpha-Gal A gene demonstrated a novel single base deletion in exon 1 (30delG). Discrepancies were observed between the enzymatic and molecular diagnoses in two at-risk females. These findings emphasize the need for precise heterozygote diagnosis by mutation and/or haplotype analyses in all families with Fabry disease.

摘要

法布里病(FD)是一种X连锁隐性疾病,由溶酶体酶α-半乳糖苷酶A(α-Gal A)活性缺乏引起。通过检测血浆或白细胞中α-Gal A活性缺乏,可确诊患病男性。然而,由于莱昂化现象,女性携带者的鉴定存在问题,需要进行突变鉴定和/或连锁研究才能准确检测携带者。在此,我们描述了一个患有法布里病的巴西大家族,借此比较生化和分子诊断技术。最初,对有患病风险的男性患者和潜在女性携带者测定血浆α-Gal A活性;男性患者很容易确诊,而女性结果不一。为检测女性携带者,使用与该基因相邻的10个多态性标记进行单倍型分析。随后,对α-Gal A基因进行固相直接测序,结果显示外显子1存在一个新的单碱基缺失(30delG)。在两名有患病风险的女性中,酶学诊断和分子诊断结果存在差异。这些发现强调,对于所有法布里病家族,都需要通过突变和/或单倍型分析进行精确的杂合子诊断。

相似文献

1
Fabry disease: comparison of enzymatic, linkage, and mutation analysis for carrier detection in a family with a novel mutation (30delG).法布里病:对一个携带新型突变(30delG)的家系进行携带者检测时酶学分析、连锁分析和突变分析的比较
Am J Med Genet. 1999 Jun 11;84(5):420-4. doi: 10.1002/(sici)1096-8628(19990611)84:5<420::aid-ajmg6>3.0.co;2-z.
2
Fabry disease in a large Nova Scotia kindred: carrier detection using leucocyte alpha-galactosidase activity and an NcoI polymorphism detected by an alpha-galactosidase cDNA clone.新斯科舍省一个大家族中的法布里病:利用白细胞α-半乳糖苷酶活性和通过α-半乳糖苷酶cDNA克隆检测到的NcoI多态性进行携带者检测
J Med Genet. 1991 Apr;28(4):232-40. doi: 10.1136/jmg.28.4.232.
3
Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes.法布里病:α-半乳糖苷酶A基因中的22种新突变以及重度和轻度受累半合子与杂合子的基因型/表型相关性
J Investig Med. 2000 Jul;48(4):227-35.
4
Fabry disease: molecular carrier detection and prenatal diagnosis by analysis of closely linked polymorphisms at Xq22.1.法布里病:通过分析Xq22.1处紧密连锁的多态性进行分子携带者检测和产前诊断。
Am J Med Genet. 1997 Aug 22;71(3):329-35.
5
Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.通过变性高效液相色谱法检测导致法布里病的α-半乳糖苷酶A突变
Hum Mutat. 2005 Mar;25(3):299-305. doi: 10.1002/humu.20144.
6
Twenty novel mutations in the alpha-galactosidase A gene causing Fabry disease.α-半乳糖苷酶A基因中的20种新突变导致法布里病。
Mol Med. 1999 Dec;5(12):806-11.
7
Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches.法布里病:新型α-半乳糖苷酶A突变的鉴定及通过荧光化学错配切割进行分子携带者检测
Biochem Biophys Res Commun. 1999 Apr 21;257(3):708-13. doi: 10.1006/bbrc.1999.0310.
8
Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations.法布里病:50个导致典型表型的新型α-半乳糖苷酶A突变的鉴定及29个错义突变的三维结构分析
Hum Genomics. 2006 Mar;2(5):297-309. doi: 10.1186/1479-7364-2-5-297.
9
Fabry disease: a new approach for the screening of females in high-risk groups.法布里病:高危人群中女性筛查的新方法。
Clin Biochem. 2014 May;47(7-8):657-62. doi: 10.1016/j.clinbiochem.2014.02.014. Epub 2014 Feb 25.
10
Contribution of clinical screening to carrier detection in a large Chinese family with Fabry disease due to a novel alpha-galactosidase A gene deletion.
Eur J Neurol. 2007 May;14(5):493-7. doi: 10.1111/j.1468-1331.2006.01611.x.

引用本文的文献

1
Diet and Physical Activity in Fabry Disease: A Narrative Review.法布里病的饮食和体育活动:叙述性综述。
Nutrients. 2024 Apr 4;16(7):1061. doi: 10.3390/nu16071061.
2
Detection of single nucleotide and copy number variants in the Fabry disease-associated GLA gene using nanopore sequencing.使用纳米孔测序检测 Fabry 病相关 GLA 基因中的单核苷酸和拷贝数变异。
Sci Rep. 2021 Nov 16;11(1):22372. doi: 10.1038/s41598-021-01749-7.
3
Fabry disease: Evidence for a regional founder effect of the gene mutation 30delG in Brazilian patients.
法布里病:巴西患者中基因突变30delG存在区域奠基者效应的证据。
Mol Genet Metab Rep. 2014 Sep 26;1:414-421. doi: 10.1016/j.ymgmr.2014.09.002. eCollection 2014.
4
CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy.法布里病的中枢神经系统受累:酶替代治疗12个月前后的临床和影像学研究
J Inherit Metab Dis. 2004;27(2):229-40. doi: 10.1023/B:BOLI.0000028794.04349.91.